Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 5HIV Infections 4Acquired Immunodeficiency Syndrome 4Sarcoma, Kaposi 3Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Tumor Virus Infections 1Triple Negative Breast Neoplasms 1Solid Cancers 1Sarcoma 1Papillomavirus Infections 1Neoplasm Metastasis 1Breast Neoplasms 1Breast Carcinoma In Situ 1Anus Neoplasms 1Advanced Neoplasm 1Adult Solid Neoplasm 1AIDS-Related Complex 1

Interventions

pembrolizumab 5Cyclophosphamide 5fludarabine 4Radiotherapy 4Irinotecan 4Mitomycin 3Interleukin-12 Subunit p35 3Fluorouracil 3Capecitabine 3Trastuzumab 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Interleukin-2 2Erlotinib Hydrochloride 2Cetuximab 2Carboplatin 2tipifarnib 1tempol 1prexasertib 1oncogene protein E7, Human papillomavirus type 16 1entinostat 1Vorinostat 1Vaccines 1Thalidomide 1Taxes 1Surveys and Questionnaires 1Specimen Handling 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1Papillomavirus Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Anus Neoplasms × Interferon alpha-2 × Clear all
NCT00000764 2021-10-28

Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
98 enrolled
Gastrointestinal

Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Anus Neoplasms, Tumor Virus Infections, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡